Spineway S.A [ALSPW] vs Bonyf N.V [MLBON] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Spineway S.A. wins in 6 metrics, Bonyf N.V. wins in 5 metrics, with 3 ties. Spineway S.A. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Spineway S.A. | Bonyf N.V. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.20 | N/A | N/A |
| Price-to-Book Ratio | 0.25 | 5.72 | Spineway S.A. |
| Debt-to-Equity Ratio | 6.63 | 0.00 | Tie |
| PEG Ratio | -2.31 | N/A | N/A |
| EV/EBITDA | -2.78 | 0.00 | Tie |
| Profit Margin (TTM) | -17.47% | 8.02% | Bonyf N.V. |
| Operating Margin (TTM) | -13.23% | -12.90% | Bonyf N.V. |
| Return on Equity | -9.46% | -32.61% | Spineway S.A. |
| Return on Assets (TTM) | -4.45% | -0.69% | Bonyf N.V. |
| Free Cash Flow (TTM) | $-3.27M | $56.95M | Bonyf N.V. |
| 1-Year Return | -18.75% | -73.29% | Spineway S.A. |
| Price-to-Sales Ratio (TTM) | 0.45 | 8.03 | Spineway S.A. |
| Enterprise Value | $3.79M | $0 | Spineway S.A. |
| EV/Revenue Ratio | 0.30 | 0.00 | Tie |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $0.01 | $-1.77 | Spineway S.A. |
| Beta (Stock Volatility) | 0.19 | -0.03 | Bonyf N.V. |
Spineway S.A. vs Bonyf N.V. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Spineway S.A. | -2.67% | 0.00% | -13.33% | -18.75% | -18.75% | -18.75% |
| Bonyf N.V. | -0.47% | -0.47% | -0.47% | -6.25% | -67.44% | -14.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Spineway S.A. | -18.75% | -18.75% | -18.75% | -18.75% | -18.75% | -18.75% |
| Bonyf N.V. | -73.29% | -64.83% | -66.24% | -66.24% | -66.24% | -66.24% |
Performance & Financial Health Analysis: Spineway S.A. vs Bonyf N.V.
| Metric | ALSPW | MLBON |
|---|---|---|
| Market Information | ||
| Market Cap | €5.76M | €2.48M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 161,971 | 2 |
| 90 Day Avg. Volume | 119,807 | 1 |
| Last Close | €0.13 | €4.20 |
| 52 Week Range | €0.10 - €0.26 | €3.96 - €15.80 |
| % from 52W High | -48.83% | -73.42% |
| All-Time High | €0.22 (Oct 15, 2025) | €19.50 (Feb 17, 2025) |
| % from All-Time High | -40.91% | -78.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.17% | 0.08% |
| Operating Margin (TTM) | -0.13% | -0.13% |
| Return on Equity (TTM) | -0.09% | -0.33% |
| Debt to Equity (MRQ) | 6.63 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.65 | €0.74 |
| Cash per Share (MRQ) | €0.10 | N/A |
| Operating Cash Flow (TTM) | €-163,000 | €56.95M |
| Levered Free Cash Flow (TTM) | €49,750 | €-36,509 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Spineway S.A. vs Bonyf N.V.
| Metric | ALSPW (Apr 26, 2026) | MLBON (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.20 | N/A |
| Forward P/E | -2.31 | N/A |
| PEG Ratio | -2.31 | N/A |
| Price to Sales (TTM) | 0.45 | 8.03 |
| Price to Book (MRQ) | 0.25 | 5.72 |
| Market Capitalization | ||
| Market Capitalization | €5.76M | €2.48M |
| Enterprise Value | €3.79M | €0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.30 | 0.00 |
| Enterprise to EBITDA | -2.78 | 0.00 |
| Risk & Other Metrics | ||
| Beta | 0.19 | -0.03 |
| Book Value per Share (MRQ) | €0.65 | €0.74 |
Financial Statements Comparison: Spineway S.A. vs Bonyf N.V.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALSPW (2024) | MLBON (2024) |
|---|---|---|
| Revenue/Sales | 11.95M | 281,483 |
| Cost of Goods Sold | 3.50M | 258,907 |
| COGS % of Revenue | 29.3% | 92.0% |
| Gross Profit | 8.45M | 22,575 |
| Gross Margin | 70.7% | 8.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -885,000 | -34,713 |
| Operating Margin | -7.4% | -12.3% |
| EBITDA | -1.11M | -33,732 |
| EBITDA Margin | -9.3% | -12.0% |
| Pre-Tax Income | -3.86M | -36,509 |
| Pre-Tax Income % of Revenue | -32.3% | -13.0% |
| Income Tax | N/A | N/A |
| Income Tax % of Revenue | 0.0% | 0.0% |
| Net Income (Profit) | -3.87M | -36,509 |
| Profit Margin | -32.3% | -13.0% |
Balance Sheet & Liquidity Metrics
| Metric | ALSPW (2024) | MLBON (2024) |
|---|---|---|
| Cash & Equivalents | 4.52M | 5,029 |
| Total Current Assets | 13.89M | 340,897 |
| Total Current Assets % of Revenue | 116.3% | 121.1% |
| Total Current Liabilities | 4.23M | 674,661 |
| Total Current Liabilities % of Revenue | 35.4% | 239.7% |
| Long-Term Debt | 1.66M | N/A |
| Long-Term Debt % of Revenue | 13.9% | 0.0% |
| Total Shareholders Equity | 24.24M | 2.64M |
| Retained Earnings | -3.87M | -4.43M |
| Retained Earnings % of Revenue | -32.3% | -1,572.4% |
| Property, Plant & Equipment | 5.93M | N/A |
Cash Flow Statement Comparison
| Metric | ALSPW (2024) | MLBON (2024) |
|---|---|---|
| Operating Cash Flow | -3.87M | 56.95M |
| Operating Cash Flow % of Revenue | -32.3% | 20,233.8% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | -3.27M | 56.95M |
| FCF Margin | -27.4% | 20,233.8% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALSPW | MLBON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 35.54M | 588,600 |
| Float Shares | N/A | N/A |
| % Held by Insiders | 0.00% | N/A |
| % Held by Institutions | 0.00% | N/A |
| % Held by Public | 100.00% | N/A |
Dividend Analysis & Yield Comparison: Spineway S.A. vs Bonyf N.V.
| Metric | ALSPW | MLBON |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |